Procurement Summary
Country : USA
Summary : Notice of Intent to Sole Source - Meso Scale Diagnostics Antibodies and Panel Kits
Deadline : 12 Jul 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 103351115
Document Ref. No. : 2024-86891
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Meso Scale Diagnostics LLC for the following specialized plates and reagents that are designed to work with MSD specific technology: SULFO-TAG Anti-Human IgA Antibody, 200 μL, SULFO-TAG Anti-Human IgG Antibody, 200 μL, U-PLEx Development Pack, 3-Assay SECTOR Plate (25 Pl), V-PLEx Respiratory Panel 1 (IgG) Kit (25 PL), V-PLEx SARS-CoV-2 Panel 2 (IgG) Kit (25 PL), V-PLEx SARS-CoV-2 Panel 38 (IgG) Kit (25 PL). This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at email@cdc.gov by COB July 12, 2024.
Active Contract Opportunity Notice ID 2024-86891 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier CENTERS FOR DISEASE CONTROL AND PREVENTION Office CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-05:00) CENTRAL STANDARD TIME, CHICAGO, USA
Original Published Date: Jun 27, 2024 02:39 pm CDT
Original Response Date: Jul 12, 2024 02:00 pm CDT
Inactive Policy: 15 days after response date
Original Inactive Date: Jul 27, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing
Place of Performance: Atlanta, GA 30329 USA
Documents
Tender Notice
Sole-Source-Justification-COSigned__Redacted.pdf